EYEPOINT PHARMACEUTICALS INC's ticker is and the CUSIP is 30233G959. A total of 3 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,454 | +117.6% | 34,600 | +137.0% | 0.00% | – |
| Q2 2023 | $127,020 | +354.8% | 14,600 | +53.7% | 0.00% | – |
| Q1 2023 | $27,930 | +16.4% | 9,500 | +216.7% | 0.00% | – |
| Q3 2022 | $24,000 | -76.9% | 3,000 | -65.1% | 0.00% | – |
| Q1 2022 | $104,000 | +550.0% | 8,600 | +561.5% | 0.00% | – |
| Q4 2021 | $16,000 | +128.6% | 1,300 | +62.5% | 0.00% | – |
| Q2 2021 | $7,000 | +16.7% | 800 | +33.3% | 0.00% | – |
| Q1 2021 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 34,600 | $276,454 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 13,200 | $105 | 0.00% |